Latest Renal cell carcinoma Stories
EAST HANOVER, N.J., Nov.
DURHAM, N.C., Nov.
Cancer drug now approved to treat rare genetic disorder SILVER SPRING, Md., Nov. 1, 2010 /PRNewswire-USNewswire/ -- The U.S.
DURHAM, N.C., Oct.
BURLINGTON, Mass., Oct.
Galil Medical Announces Columbia University Medical Center Enrolls First Patient In Renal TRACE Registry Galil Medical's TRACE Renal Registry tracks the use and effectiveness of kidney cryotherapy.
SAN DIEGO, Oct. 11 /PRNewswire/ -- More than 120 cancer survivors and caregivers, cancer-treating physicians, and patient advocates gathered in San Diego to share their ProleukinÂ® (aldesleukin for injection) treatment experiences.
DURHAM, N.C., Oct. 8 /PRNewswire/ -- Argos Therapeutics today announced that Jeff Abbey, the company's president and chief executive officer, will present recent clinical developments and a corporate overview at the 18th Annual BioPartnering Europe conference in London at 12:15 p.m.
NEW YORK, Oct. 7 /PRNewswire-FirstCall/ -- Pfizer Oncology will present new data across its portfolio representing novel approaches to researching treatments for patients with rare and difficult-to-treat cancers.
CHICAGO, Oct. 1 /PRNewswire/ -- Argos Therapeutics announced that its Arcelis immunotherapy for renal cell carcinoma (RCC), AGS-003, demonstrated favorable progression-free survival (PFS) and safety in combination with sunitinib, based upon updated results from an ongoing Phase 2 trial.